Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-14-069943

Options or other derivatives

  • Chief Technology Officer acquired 28,140 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

GRAZIANO JAMES JOSEPH · Chief Technology Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2014-11-18 Grant or award : show line 1 in the form Common Stock Option (right to buy) +28,140 28,140 D
Loading xslF345X03/form471632_20141120093121-.xml…